The plan will provide a much-needed strategy to address the burden of cancer in the European Union. The European Commission has opened a public consultation to gather stakeholder input on the plan.
The Health Policy Partnership is pleased to have contributed to this public consultation, building on the policy discussions around radioligand therapy at the European Parliamentary meeting and aligning with the European policy report recommendations. In order to optimise overall cancer treatment and radioligand therapy for all people with cancer in Europe, we urge the European Commission to prioritise:
We hope that the Commission will consider these priorities in Europe’s Beating Cancer Plan to help mitigate existing barriers to the availability of effective treatment options, such as radioligand therapy.
The full submission is available to download on the European Commission’s website.